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Introduction: 
Philosophers and others trying to define “disease” often frame their projects as 
conceptual analysis, aiming to identify the concept’s meaning or proper application.  
Christopher Boorse’s work certainly fits this model.  In his presentation of the 
Biostatistical Theory (BST), he provides short and precise definitions for “disease” and 
“health,” shows how they fit expert usage, and argues that alternative accounts do not do 
so as well (Boorse 1975, 1977, 1987, 1997, 2011). Debates in contemporary analytic 
philosophy are framed as conceptual analysis in a wide range of areas, from discussions 
of “knowledge” and “justification” in epistemology, to “free will” and “personal identity” 
in metaphysics, to “justice” in moral theory (Ramsey 1992, Bealer 1998, Margolis and 
Laurence 2012) 
But the project of conceptual analysis has been convincingly critiqued as relying 
on problematic assumptions about the existence, meaning, and use of concepts (Ramsey 
1992, Millikan 1989, Stich 1992, Margolis and Laurence 2012).    I agree with these 
critiques and have argued that attempts to define “health,” “disease,” and “function” 
should avoid any claim to be discovering the meaning or correct criteria of application of 
these concepts (Schwartz 2004, 2007a). Instead, I believe that philosophers of medicine 
and biology should adopt an approach described by W.V.O. Quine and Rudolf Carnap 
that presents philosophical accounts of concepts as new definitions for old terms (Quine 
1960, Carnap 1950).   From this perspective, accounts should be evaluated as proposals 
about how to define a term in the future, not as discoveries about the current meaning or 
criteria of application (Schwartz 2004, 2007a).   
Quine (1960) describes this project, which I term philosophical explication, as 
beginning with the recognition that a useful expression is "somehow troublesome": " . . . 
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it is vague in ways that bother us," he writes, "or it puts kinks in a theory or encourages 
one or another confusion" (Quine 1960, 260).  Philosophers respond by proposing new 
definitions for the expression that would allow it to continue to be useful without raising 
the problems: 
We do not claim synonymy.  We do not claim to make clear and explicit what the 
users of the unclear expression had unconsciously in mind all along.  We do not 
expose hidden meanings, as the words ‘analysis’ and ‘explication’ would suggest; 
we supply lacks.  We fix on the particular functions of the unclear expression that 
make it worth troubling about, and then device a substitute, clear and couched in 
terms to our liking, that fills those functions. (Quine 1960, 258-9) 
Carnap provides a similar description for his project (Carnap 1950, 3-8).1  Interestingly, 
in a recent article, Boorse has framed his approach in a way that would be consistent with 
philosophical explication (Boorse 2011, 20), but he does not appear to recognize the full 
significance of redefining his project in this way and does not follow through.   
In this paper, I will review the attacks on conceptual analysis and describe the 
implications of reframing the disease debate as philosophical explication.  Perhaps most 
importantly, adopting the methodology of philosophical explication focuses discussion on 
normative questions, in this case about how concepts of disease and health should be 
used in biology and medicine.  This represents a key shift from conceptual analysis’s 
focus on discovering what concepts mean.  In the final two sections of the paper, I 
describe how framing the disease debate as philosophical explication helps clarify and 
respond to two criticisms that have been directed at the BST and, more generally, at the 
entire philosophical project of trying to define “disease” and “health” (Engelhardt 1976, 
1984, van der Steen and Thung 1988, Hesslow 1993, Amundson 2000, Hausman 2011). 
From the perspective of philosophical explication, both attacks can be best understood as 
critiquing the assumption that these concepts have valuable theoretical roles to play in 
biology and medicine. Once the attacks are seen in this way, I argue that there are clear 
responses available to Boorse and others who aim to define “disease.”  These responses 
involve normative claims, and the ones supporting the BST are particularly strong, since 
they draw on essential aspects of biomedical science and can be linked to Norman 
                                                 
1 For a recent discussion of Quine’s approach, see Ebbs (2011, p. 623). 
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Daniels’s influential account of healthcare justice (Daniels 2008).  In addition, 
considering BST as a potential philosophical explication of disease helps defend 
Daniels’s account from a recent criticism (Hausman 2011), as I discuss in the last part of 
Section 4.   Understanding definitions of “disease” as proposed philosophical explications 
blurs the line between philosophy of medicine and medical ethics in ways that are 
probably salutary for future progress in both areas. 
 
1. The Conceptual Analysis of Disease and Health:  
 
Defining Disease as Conceptual Analysis: 
The contemporary debate over how to define disease stems from uncertainty and 
controversy about how to apply this concept in medical practice, policy, and ethics 
(Boorse 2011, 13-15).  Some of these controversies involve questions about whether a 
certain condition should count as disease, as in debates over how to classify 
homosexuality, alcoholism, or short stature (Boorse 2011, 13-19)  On a more general 
level, “anti-psychiatry” writers such as Thomas Szasz question the reality of all mental 
illness (Szasz 1961).  For some conditions, such as attention deficit disorder and 
depression, the debate focuses not on whether the condition is a disease but instead on 
where to draw the line between disease and normality.   When is a short attention span or 
an overbearing sense of hopelessness extreme enough to be pathological?  
Philosophers respond by proposing criteria for identifying and delimiting disease.  
The criteria are often presented as conceptual analyses, i.e., characterizations of the 
meaning of the concept or its proper criteria of application (Schwartz 2007a, Lemoine 
2013).  Boorse’s writings fit this model well.  He characterizes his project as “trying to 
sort out various notions of health” (Boorse 1977, 542-3).  He refers to his theory as being 
“an analysis of disease” and asserts that it captures the “underlying concept of health” 
(Boorse 1977, 568).  Later, he writes that his theory, now titled the Biostatistical Theory 
(BST), aims at providing “a clear analysis” of concepts of health and disease (Boorse 
1997, 55). 
In multiple places, Boorse acknowledges that the term “disease” is rarely used as 
widely as his theory assumes – to include injuries, syndromes, and congental defects, for 
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instance – although he points out that at least some uses of the word range this widely (as 
in the title of the AMA’s Nomenclature of Diseases and Operations (emphasis added, 
cited in Boorse 1987, 362).  He says he is interested in defining “disease” as a synonym 
of the scientific term “pathological,” and he asserts that “the distinction between normal 
and pathological conditions is the basic theoretical concept of Western medicine.” 
(Boorse 1987, 364-5)  Boorse explicitly limits his focus to the concepts of health and 
disease at work in medical science, not the concept or concepts employed by laypeople. 
Boorse’s arguments for his account also fit within the model of conceptual 
analysis. He shows that his account’s classifications match those of experts, often 
referencing biological or medical textbooks, and he argues that rival accounts fail to 
match as well (Boorse 1975, 1977, 1987, 1997, 2011).  He treats his theory and rivals as 
attempts to explain the ways that medical science classifies conditions.  For instance, 
Boorse critiques Engelhardt’s account of disease as doing little “to explain the actual 
medical inventory of disease.  Such accounts cannot explain this inventory because they 
cannot predict it.” (Boorse 1977, 567) The expectation that an account of “disease” can 
explain current usage only makes sense if the definition aims to capture the concept’s 
intension, which then determines which objects fall within its extension.  
 
Problems with Conceptual Analysis: 
For all these reasons, Boorse’s project appears to be conceptual analysis, of a sort 
that is at least roughly similar to standard practice in analytic philosophy.  But this sort of 
conceptual analysis faces important challenges, generally stemming from problems with 
key assumptions regarding the existence, meaning, and criteria of application of concepts 
(Ramsey 1992, Margolis and Laurence 2012). Perhaps most importantly, philosophers 
and psychologists question whether concepts have meanings that can be stated precisely 
(Margolis and Laurence 2012, Ramsey 1992).  A central strand of analytic philosophy, 
seen clearly in Wittgenstein’s (1958) and Quine’s (1960) seminal accounts, challenges 
the assumption that terms or concepts have identifiable meanings that are the same for 
different competent speakers.   
Even more questionable is the assumption that concepts’ meaning can be 
discovered through “armchair” philosophical methodology, i.e., reflecting on expert 
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usage in actual situations and intuitions about proper application in hypothetical cases.  A 
large literature has arisen questioning whether philosophers’ opinions and intuitions are 
reliable on such matters and whether certain sorts of experimental approaches might be 
more appropriate (Cummins 1998, Margolis and Laurence 2012, Ramsey 1992, 
Weatherson 2003, Weinberg et al. 2010, Horvath 2010). 
Some philosophers defend the project of conceptual analysis by arguing that the 
goal is not to identify the meaning of concepts but instead the criteria of application that 
is understood implicitly by experts (Neander 1991).  While this sidesteps questions about 
meaning, it raises other challenges.  First, philosophers’ accounts are often a short list of 
necessary and sufficient conditions and thus do not resemble the sort of criteria of 
application uncovered by psychological research, which involve mechanisms such as 
prototypes and similarity metrics (Rosch and Mervis 1975).  Second, if the goal is to 
identify criteria of application that are currently being used by experts, it appears that 
empirical, psychological research would be more appropriate than philosophical 
reflection.  Finally, if philosophical definitions are being offered as accounts of expert 
usage, then it should be at least somewhat concerning that those very same experts are 
often skeptical or dismissive of the definitions that philosophers offer.  
Another basic criticism of conceptual analysis points out that philosophers 
pursuing this project often produce multiple incompatible accounts, where each one 
works well for some cases but not all: each proposed definition classifies many 
paradigmatic cases in currently accepted ways (i.e., in accordance with current usage or 
with intuitions about proper usage in hypothetical situations), but fails to do so for other 
cases.  Supporters of each account then try to show that the failures of rival accounts are 
more concerning than those that face their own account, a debate that has been 
characterized as echoing with “the dull thud of conflicting intuitions” (Bigelow and 
Pargetter 1987, p. 196).2 
                                                 
2 Lemoine (2013) has recently described these standoffs in the debate over “disease” and 
discussed how they limit the ability of conceptual analysis to settle the debate between naturalism 
and normativism.  His proposed response to these problems with conceptual analysis, though, 
differs from mine. 
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Boorse’s BST, for instance, matches expert usage of the terms “disease” and 
“health” extremely well, as he has defended in multiple publications over 40 years (1975, 
1977, 1987, 1997, 2011).  But even the BST deviates from currently accepted use in 
some ways.  For instance, standard reference works characterize certain rare 
abnormalities as pathological, even though they do not involve dysfunction and thus 
would not count as disease according to the BST (see Boorse, this issue).  Also, as 
Boorse has discussed, it appears that the BST would not count diseases that have been 
prevalent for a long period or at certain ages as pathological.3  Other accounts of disease 
produce even more striking discrepancies with current assumptions about proper usage.  
Wakefield’s Harmful Dysfunction Account would not count depression as a disease if it 
were produced by a mechanism that was favored by natural selection in similar situations.  
Culver and Gert’s Malady account classifies pregnancy as pathological, since it confers 
increased levels of risk (Gert, Culver, and Clouser 1997, 126). 
There are two general strategies available for a theory to respond to such 
deviations from current usage. First, a philosopher can tweak his account to eliminate the 
discrepancy, i.e., to classify an actual case as experts do or to classify a hypothetical case 
as experts and/ or philosophers think they should.  Second, the philosopher can argue that 
the current usage or assumptions are incorrect.  Boorse, Wakefield, and 
Gert/Culver/Clouser all take the second approach to the discrepancies described above, 
arguing that current assumptions about proper usage or meaning are mistaken or should 
be changed.   
Can such recommendations be understood as consistent with the traditional 
understanding of conceptual analysis, as resulting from a discovery about the meaning or 
correct criteria of application of the concept of “disease”?  Lemoine (2013) has recently 
suggested that such proposals should be considered as simply “marginal stipulations” that 
clarify or change current understandings in only small ways.  From this perspective, the 
true meaning is not affected by such changes, since the cases are minor. While I cannot 
comment at length on this approach, one may ask for clarification of what it means for a 
change to be “marginal” rather than substantial, and to question whether classifying 
                                                 
3 Hausman’s paper in this issue, though, proposes an approach for applying the BST that might be 
able to avoid this counter-intuitive conclusion. 
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universal disease (for Boorse) or depression (for Wakfield) as healthy can count as minor 
changes. It seems more likely that any change, even a clarification along the borders, 
should count as a change or modification in the meaning (both intension and extension) 
of the concept. 
A way of interpreting recommended changes that is more consistent with the 
traditional view of conceptual analysis is to assert that the philosophical investigation has 
discovered the true meaning of the concept or the correct criteria of application, even 
though it differs from the best understanding of experts and philosophers up till now.  
From this perspective, there was a true intension and extension of the concept that existed 
but was not known before, but which has only now been uncovered.  This view of 
changes imposed by conceptual analysis faces important questions about what sort of 
entity is meaning or criteria of application that could somehow lurk behind the usage of 
experts and only be uncovered through philosophical investigation?  As mentioned 
above, the seminal work of Wittgenstein and Quine provides good reasons to question 
such a view.   
Anti-individualist approaches to natural kinds fits this picture, where there are 
meanings that may not be known by experts and can be discovered through investigation.  
Ruth Millikan draws on this model to propose that her analysis of “function” is the sort 
that “the scientist gives you in saying that water is HOH, [or] that gold is the element 
with atomic number 79, …” (Millikan 1989, 291).  Dominic Murphy (2006) characterizes 
his analysis of “mental disorder” similarly.  But while such an approach at least tries to 
address the question of how meaning can be discovered, it raises other problems, 
including whether definitions of natural kinds can be characterized as discoveries rather 
than decisions (Ebbs 2000, Laporte 2004). In addition, it seems unlikely that the terms 
“disease” or “health” are natural kind terms, or sufficiently similar to them, to use an 
anti-individualist approach.   (For further discussion of problems with Millikan’s 
approach to characterize the discussion of “function” and “disease”, see Schwartz 2004, 
2007a). 
Instead of attempting to shoehorn debates over “disease,” “health,” and 
“function,” into a model where philosophical analysis uncovers the true meaning or 
criteria of application of these concepts, philosophers should accept that they are offering 
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new definitions for old terms or concepts.  Such a shift, to a project I term “philosophical 
explication,” has important and salutary implications for this discussion.  
 
2. Philosophical Explication: 
Philosophical explication avoids the problems raised by conceptual analysis by 
eschewing any claim to be discovering the meaning of a term or the correct criteria of 
application.  Instead, definitions are considered as proposals about how to use language 
in the future.   Some philosophers reject this way of characterizing the project due to its 
appearing pragmatic rather than philosophical.  A full response to such concerns would 
require a broad evaluation of pragmatism and its relation to other approaches in analytic 
philosophy, which I cannot provide within the scope of this paper (See Jackson 1998, 
Horvath and Grundmann 2010, and Margolis and Laurence 2012, Section 5).  But the 
discussion so far should motivate at least an exploration of how the disease debate would 
change if it were reframed as philosophical explication.  In this section, I will describe 
three implications of this shift. 
 
First implication: Deviations from current usage: 
Shifting from conceptual analysis to philosophical explication completely 
reframes deviations from current usage.  From the perspective of philosophical 
explication, deviations are not just acceptable but actually expected.  The currently used 
concept is not clearly defined, or it is defined in ways that are problematic, and thus a 
new definition is desirable.  There is no reason to expect that the newly defined concept 
will apply to all and only the same things that the old concept did.  Current ideas about 
“disease” and “health,” for instance, involve metaphorical ideas about how living things 
should be or perhaps what a designer planned when creating them (Schwartz 2007b).  
These are exactly the sort of problematic ideas that motivate a philosophical explication, 
and eliminating them, as the BST does, can be expected to create at least some shifts in 
application. 
 After acknowledging that his account does not perfectly fit expert usage, Boorse 
approvingly cites Nordenfelt’s view (Nordenfelt 2001, 26) that the BST “may be best 
described as a rational reconstruction of a scientific concept in the style of Carnap, 
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Hempel, or Quine, with stipulative precisifications and exclusions.” (Boorse 2011, 20)  In 
this passage, Boorse suggests a project of philosophical explication, but he appears not to 
recognize the implications of this shift.  Immediately after this comment, he aligns his 
work with Karen Neander’s, even though she unapologetically sees her theory as 
conceptual analysis (Neander 1991).  And he describes accounts as being “wrong” if they 
fail to fit medical usage, although that term does not apply if the goal is to propose new 
definitions.  Perhaps most importantly, he never explicitly redefines his task as creating a 
new definition, rather than as characterizing the concept currently being used in medical 
science.   
 
Second implication:  Reframing standoffs:  
Shifting from conceptual analysis to philosophical explication also reframes the 
nature of debates between competing accounts.  As described above, philosophers often 
propose incompatible accounts, each of which has advantages and disadvantages.  
According to conceptual analysis, only one of these accounts correctly captures the true 
meaning or correct criteria of application. In philosophical explication, in contrast, the 
two definitions may each have a reasonable claim to being the one that should be adopted 
in the future. For instance, one account may be somewhat better suited for one theoretical 
role while the other may be better suited for other roles.  One definition may be easier to 
apply and the other may require fewer changes from current usage.  There may still be 
debate between accounts, but that debate is over which should be adopted, not which is 
correct. 
 
Third implication: Normativity and theoretical roles: 
As this example shows, when the debate is reframed as philosophical explication, 
the focus shifts to clearly normative arguments about how concepts should be used in the 
future, and central to that question is identifying and justifying the specific theoretical 
roles these terms will play.  These are issues that arise but are often downplayed when the 
debate is seen as conceptual analysis. 
The key theoretical roles of “disease” and “health” seem to fall into two 
categories.  First, there are roles in medicine, involved in directing medical practice, 
Reframing the Disease Debate 10 2014-8-11 
ethics, and policy. Second, there are roles in biology, in organizing and pursuing the 
science, perhaps especially in the subfield of pathology.  The disease debate stems largely 
from controversies in the first area, relating to debates over the disease status of particular 
conditions and types of conditions.  Boorse recognizes the importance of such debates but 
focuses on the second area, writing that his aim is to “capture a concept of health – 
freedom from pathological conditions – in theoretical scientific medicine,” (Boorse 2011, 
19), and to find “a lexical definition of ‘pathological condition’ in physiological 
biomedicine” (Boorse 2011, 20).   
In the final two sections of this paper, I will examine and respond to two 
criticisms of the BST that assume that the definition is a proposed conceptual analysis.  I 
will argue that both attacks are best understood as questioning the entire project of 
performing a conceptual analysis in this area at all, and thus, I argue, both can be 
answered at least in part by reframing the disease debate as philosophical explication.  
The first attack focuses on the theoretical roles of “disease” in biology and medical 
science, while the second one focuses on theoretical roles in clinical medicine.   
Both responses involve defending the importance of crafting a philosophically 
adequate definition of “disease” to play these roles, and thus depend on the normative 
claim that such a concept should be used in biology and medicine in the future.  Linking a 
definition of disease to normative claims might be expected to weaken the theory, since 
reasonable people may disagree about normative claims such as what should happen in 
the future.  But I will argue that the normative claims associated with BST are strong 
enough that acknowledging them strengthens the account rather than weakening it.   
 
3.  Does Biology or Medical Science Need a Concept of Disease? 
 In biology, the key role for a distinction between health and disease is delimiting 
the range of conditions or states of an organism that can be characterized as “normal” in 
anatomy, physiology, etc.  Any generalization about how some tissue, organ, or molecule 
is structured or what it does, and how it interacts with other parts of the organism, may 
not apply to individuals with certain diseases.  The human heart pumps blood and 
maintains perfusion of tissues, for instance, but not in individuals with heart failure.  
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Therefore, some argue, biology relies on a notion of “health,” and a contrary notion of 
“disease,” in setting the range over which its generalizations hold. 
A number of critics have claimed that a concept of “health” or “function” cannot 
play this role in modern biology (Engelhardt 1976, 1984, van der Steen and Thung 1988).  
These critics point out that biology recognizes that variation is central to living things and 
rejects the idea of a species type, at least since the discovery of evolution and natural 
selection (Sober 1980).  They conclude that given this aspect of biological theory, any 
generalizations about how organisms are “normally” structured or work must be suspect 
(Engelhardt 1976, 1984, van der Steen and Thung 1988, Amundson 2000).  
Boorse (1997) responds to such attacks in part by pointing out that biomedical 
science does, in fact, make such generalizations about both the healthy state and the 
impact of diseases.  To illustrate, he reproduces a three-page table from a standard 
textbook regarding the functions, paths, and connections of the cranial nerves of humans, 
showing the many regularities that have been identified (Boorse 1997, 34-36).  As he 
says, the recognition of the importance of normal variation, and the absence of species 
types, has not led to rejection of generalizations about how living things are structured 
and how they work. This is how biologists think and present their science, he argues, and 
thus his account can be defended as a conceptual analysis of the meaning of their terms. 
Shifting to the perspective of philosophical explication changes the attack and the 
response.  From the perspective of philosophical explication, the critic should be seen as 
arguing not whether medicine does make such generalizations but whether it should.  
Although biologists do make such generalizations, the critic could claim, the importance 
of variation and the rejection of species types should undermine acceptance of them.  
But if the attack is taken in this way, there is also a possible response for Boorse 
or any philosopher defining “disease.”  One can admit that there is tension in biology 
between making generalizations about living things and recognizing the existence of 
variation.  In fact, this very tension requires a notion of “health” to explain the range over 
which generalizations apply.  Boorse or others can admit that the current concepts of 
“disease” and “health” are vague and problematic, and possibly infected by metaphorical 
ideas about how things should be.  But this does not undermine their accounts of 
“disease.” Rather, these are exactly the sort of “kinks in a theory” that Quine wrote about, 
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which make a currently useful concept troublesome and mandate replacement with a 
well-drawn term.  The BST or any account should be tested for whether it involves only 
acceptable biological notions and whether it can play the theoretical role of determining 
the range of application for generalizations about the healthy state of organisms.  It 
appears that BST fits both these desired characteristics.  
Admittedly, the critic may still claim that instead of adopting the BST, biology 
should instead do without a notion of health and disease, and thus should stop making the 
sort of generalizations that it would allow.  But this critique is well answered by Boorse’s 
example of the successful generalizations about the human cranial nerves. Such 
generalizations appear to be valuable products of science and to be practically useful.  It 
is thus attractive to accept BST or another workable account and continue making such 
generalizations, rather than simply giving up the practice.  It is important to note that 
while this is a normative claim, about how science should be carried out, it is not clearly 
a moral claim. 
A critic of the BST might accept the importance of the theoretical role but still 
claim that a simpler approach could be taken:  perhaps generalizations in biology could 
be seen as just describing what typically happens.  But this will not work well:  As Ruth 
Millikan has pointed out, some examples of health and proper functioning may be quite 
unusual statistically:  For instance, only one in 1000 turtle eggs may successfully develop 
into a healthy adult (Millikan 1993).   
 
4.  Does Clinical Medicine Need a Concept of Disease? 
 
Theoretical Roles for “Disease” in Medicine: 
 The second sort of attack involves the theoretical roles of “disease” in clinical 
medicine.  Since Hippocrates the medical profession has defined itself as focused on 
treatment of disease and illness, with doctors taking the famous oath to enter the homes 
of the ill.  In the contemporary debate, prominent ethicists have argued that medicine 
should be defined as combating disease, in particular on preventing, curing, and 
ameliorating the effects of disease (c.f. Brody and Miller 1998, Miller, Brody, and Chung 
2000, Miller and Brody 2001, Callahan 1996) 
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At the same time, there has been much controversy over whether and how to limit 
or direct the practice of medicine towards disease (c.f. Arras 2001, Beauchamp 2001). 
Doctors currently prescribe contraception and perform abortions, give botox injections to 
smooth out wrinkles in aging skin, and perform rhinoplasties (nose jobs), all in the 
absence of any disease.  Some argue that such medical activities are inappropriate and 
that doctors should not perform them (Kass 1971, 1975).  But there is general acceptance 
of such practices in many cases, certainly if the side effects are minimal and autonomous 
adults give informed consent.  At the same time, most such medical interventions are paid 
for by the patient, reflecting the widespread belief that health insurance should pay only 
when disease is involved.   
For some types of “enhancements,” cases where the target is not disease but 
instead making people “better than well,” controversy arises over whether it is ethical for 
doctors to act.   Many would argue against allowing doctors to conduct certain types of 
genetic engineering or prescribe medication to increase memory or eliminate the need for 
sleep in perfectly healthy people, even if the patients were paying out of pocket (Kass 
1971, 1975, Sandel 2004).  At the same time, some ethicists argue that such interventions 
would be perfectly appropriate, perhaps as long as steps were taken to make sure they 
were widely available (Caplan, McGee, and Magnus 1999, Caplan and Elliott 2004).  In 
summary, although there is controversy about many real and possible enhancements, 
there appears to be general acceptance that whether a condition counts as a disease is at 
least somewhat relevant to determining the ethical practice of medicine and health 
insurance coverage.  
 
Hesslow’s Attack: 
In a paper entitled “Do we need a concept of disease?” Germund Hesslow 
presents powerful criticisms of accepting this sort of theoretical role for “disease” 
(Hesslow 1993).  First, he argues that the presence of disease is irrelevant for questions 
about what doctors should ethically do.  The key issue, he argues, is just whether the 
condition has undesirable consequences and whether there is a safe and effective way to 
treat it.  As an analogy, he points out that it would be ridiculous for a mechanic to refuse 
an owner’s request to adjust his car’s valves to increase acceleration just because there is 
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“nothing wrong” with the valves as they are currently adjusted (Hesslow 1993, 1-3).  The 
question of whether to adjust the valves involves identifying any tradeoffs (e.g., perhaps 
reduced fuel efficiency) and making those clear to the owner.   
Hesslow (1993) then moves on to critique the assumption that health insurance 
should cover only conditions where disease is present or threatened.  He points out that 
the real goal of an insurance scheme is to “spread risks more evenly for events which are 
costly, difficult or impossible to predict, outside the control of the individual and 
undesirable by almost everyone” (Hesslow 1993, 8).  House fires fit this model and thus 
are covered by home insurance; many diseases also fit this model and thus should be 
covered by health insurance.  But what matters in that case, he argues, is not whether the 
condition is a disease or not, but instead whether it fits the scheme that justifies all sorts 
of insurance.  As he points out, nearsightedness is clearly dysfunction, and thus disease 
by Boorse’s account, but its treatment is not covered since the condition is common and 
treatment is not particularly costly (Hesslow 1993, 8) 
Hesslow presents his attacks as criticisms of pursuing a conceptual analysis of 
disease.  At the same time, his points about what doctors and designers of medical 
insurance should do may appear somewhat irrelevant to the classic question of conceptual 
analysis, i.e., what is the meaning of concepts they are actually using.  If doctors or 
insurers do care about what is and is not disease, why does it matter whether they should?  
Arguments about what they should do are much more relevant to philosophical 
explication.  From this perspective, Hesslow’s points have more force:  I.e., given that the 
current concept of disease is vague and problematic, he could argue that it is better to 
simply eliminate the concepts of “disease” and do without the theoretical role it has been 
playing, for the reasons he presents, rather than to adopt a more precise and scientific 
definition.  In other words, he might have a stronger argument against BST (or another 
account) as a philosophical explication of “health” and “disease,” rather than as a 
conceptual analysis.  
 
A Response:  Daniels’s Account of Healthcare Justice 
 If Hesslow’s argument is taken in this way, as a critique of philosophical 
explication of “disease,” then responding to his points requires making a convincing 
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normative or moral argument that the concept of “disease” should play an important role 
in directing medical care or insurance.  Luckily, there is such a normative account, 
presented, defended, and developed over the last 30 years by Norman Daniels.  Daniels’s 
account of healthcare justice makes the presence of disease central to medical ethics and 
policy.  I cannot do full justice to Daniels’s approach (for that see especially (Daniels 
2000, Daniels 2008, Daniels 2009)) but let me introduce the key issues as a way to 
respond to Hesslow’s concerns.   
For Daniels, the key role of medical care or public health, at least as far as they 
contribute to justice, is protecting fair equality of opportunity.  According to the theories 
of John Rawls, which serve as a backdrop to Daniels’s account, it is acceptable for some 
individuals to have more primary goods than others as long as this inequality increases 
the primary goods available to the least well-off representative individuals (the 
“Difference Principle”) (Rawls 2001, 2005).  But Rawls’s account also requires that all 
individuals must have a “fair equality of opportunity” to compete for the desirable goods 
or opportunities, or the positions that carry such rewards.  This does not mean that 
everybody must have an equal opportunity to compete.  For instance, those born with 
more intelligence or other skills may have a superior chance to obtain desirable positions 
and the opportunities or goods that go with them.  But to satisfy fair equality of 
opportunity, individuals with similar levels of skill and willingness to apply those skills 
should have similar chances to obtain the desirable positions or goods (Rawls 2001, 43-
44).  
Although fair equality of opportunity plays this key role in Rawls’s account, and 
in other accounts of justice, it is admittedly somewhat difficult to define.  It is certainly 
violated in a feudal society, where opportunities and life plans are determined largely by 
family of birth.  Fair equality of opportunity is also clearly violated if opportunity is 
limited by law or practice based on race or ethnicity.  But even after feudal or racist laws 
have been eliminated, a society will still have failed to achieve fair equality of 
opportunity if people born into families with limited resources have greatly limited 
opportunities to develop and apply their skills. (Daniels 2008, 51-56)  For Rawls, the 
need to protect fair equality of opportunity provides argument that public schools and 
child labor laws are requirements of justice.  
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Daniels extends Rawls’s theory to health and healthcare by arguing that disease 
also reduces fair equality of opportunity.  If two people have similar skills and 
willingness to apply them, then if one of them has a disease and thus cannot compete 
effectively, fair equality of opportunity has been compromised (Daniels 2008, 57-60).  In 
Daniels’s account, this creates the basis for public health efforts and for a basic health 
insurance package available to all, through public or private mechanisms.  To define 
“disease,” Daniels favors a dysfunction-requiring account such as Boorse’s, since it 
provides a relatively objective test for when disease is present (Daniels 2008)(see pp. 36-
42). 
Note that Daniels’s theory does not imply that every possible treatment for 
disease must be covered by a basic health insurance package. He spells out a variety of 
mechanisms for making reasonable determinations about how to balance cost, efficacy, 
and adverse events in determining whether to include a specific intervention in a standard 
healthcare package.  In addition, Daniels’s account allows that some interventions may be 
covered even though disease is not present or threatened, as in the case of contraception 
or care for a healthy pregnancy, due to other issues of justice. (See (Daniels 2000, 313-
14), and (Daniels 2008, 103-139).) 
Thus, Daniels’s account provides a way to answer Hesslow’s attack on using the 
presence of disease to organize or provide healthcare insurance and public health.  It 
provides a basis for making a distinction between treatment of disease, on the one hand, 
and enhancement of the normal, on the other.  For example, if lead in a home would 
hinder a child’s intellectual development, then removing that lead would serve fair 
equality of opportunity by eliminating an impediment to his fully developing and 
applying his skills. In contrast, if a medication could increase intelligence of perfectly 
healthy children, providing that medication would not increase fair equality of 
opportunity.  That medication would not in any sense remove an impediment to full use 
of skills and willingness to use them.4 
                                                 
4 And this distinction has nothing to do with the level of functioning in the “untreated” cases:  
removing lead from the home is a proper focus of public health even when the lead-affected child 
would have had an IQ of 120 and elimination of the lead would raise that to 130.  Similarly, even 
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Answering A Criticism of Daniels:  
There is a voluminous literature of criticisms and defenses of Daniels’s approach, 
which I cannot survey here.  (See Daniels’s statements of his theory and response to 
critics at (Daniels 2008, Daniels 2009)).  But one recent criticism of Daniels can be 
answered in part by recognizing the attempt to define disease as philosophical 
explication.  In this way, just as Daniels’s account can help strengthen and justify the 
pursuit of a philosophical explication of disease, and thus answer some of the points that 
Hesslow (1993) made, so too can reframing the disease debate as philosophical 
explication help defend Daniels’s account.   
Daniel Hausman has critiqued Daniels account by pointing out the difficulty of 
determining whether a condition is a disease or a part of healthy variation (Hausman 
2011).  For instance, if a short attention span is classified as a disease, as in attention 
deficit disorder, then its negative impact on opportunity is a violation of fair equality of 
opportunity and treatment should be covered by health insurance.  But if a short attention 
span is just part of normal variation –people have shorter and longer attention spans, after 
all – then any negative consequences on opportunity are simply limitations in the 
individual’s skill set.  In this case, there is no violation of fair equality of opportunity, and 
treatment is not justified.  
Hausman points out that there are no clear rules for drawing the line between 
normal and disease (Hausman 2011, 184-6).  In a previous paper, I termed this the “line-
drawing problem” (Schwartz 2007b): the BST and any other dysfunction-requiring theory 
must distinguish between levels of functioning that are below average, and undesirable, 
but part of normal variation (and thus healthy) vs. levels that are so low that they 
represent dysfunction.  This challenge can be seen in the example of attention span, but 
also applies to organs involved in physical function, like hearts’ pumping blood.  In men 
ages 40-50, for instance, an ejection fraction of 40% may fall below average and may 
reduce exercise capacity and thus be undesirable, but this ejection fraction may still fall 
in the normal range of variation and thus not count as dysfunction or disease.  When is an 
                                                                                                                                                 
if the pill increases the IQ of the perfectly healthy child from 90 (below average but not 
abnormal) to 120, it is still an enhancement, not treatment.   
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ejection fraction low enough to count as not just undesirable but also abnormal or 
unhealthy? (Schwartz 2007b) 
There is a significant challenge, I argued, to drawing this line.  While Boorse has 
suggested that the line should be drawn based on prevalence in the reference class, this 
cannot work, in part due to the possibility of very prevalent disease (Schwartz 2007b).  I 
have proposed that the line should be drawn at least in part based on facts about the 
severity of consequences of the level of functioning, and Hausman has offered some 
further proposals (Hausman 2012), including an excellent discussion in this issue.   
But no matter what approach is adopted, there is no question that drawing the line 
between health and disease will be somewhat arbitrary.  Given this, Hausman argues that 
putting so much weight on it, as Daniels does, is a serious problem for his theory 
(Hausman 2011, 185).  
Here I would like to suggest that seeing the disease debate as philosophical 
explication helps weaken Hausman’s complaint.  It is a natural part of a philosophical 
explication that the new definition for a previously vague and problematic concept will 
impose at least some changes in proper usage and impose new precision.  And, in 
keeping with philosophical explication, it may be that a range of ways of drawing key 
distinctions will be acceptable.  But once such a line is drawn, there is no reason why it 
cannot be used to make important, even life altering, distinctions.  
As an analogy, consider arguments over the proper definition of “fraud.”  Going 
back hundreds or thousands of years, people have distinguished between aggressive but 
fair business practices and unfair or criminal practices.  There are always difficult cases, 
where opinions differ about whether the practice crossed the line into criminal or 
unethical behavior.  There may also be disagreement about even the basis for drawing a 
line, perhaps in areas such as new types of commerce or products.  In response, each 
society engages in an extended project of writing laws and developing case law regarding 
how to draw these lines, in essence going through a process roughly analogous to a 
philosophical explication.   Similar points could be made about ideas such as 
manslaughter, self-defense, or negligence.  In each case there are key ethical and policy 
commitments that need to be clarified, defined, and made precise to be used widely. 
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But note that in none of these cases does the need for drawing such lines, and 
even recognition that the lines could be drawn in a variety of places, make it unethical or 
unjust to make consequential decisions based them.  And of course the implications are 
often serious:  what counts as fraud may determine whether a businessmen goes to jail or 
is promoted to CEO.  Similarly for the lines that a philosophical explication of “disease” 
must draw:  the implications will be serious, and the lines will require key decisions that 
most likely express moral conclusions, but it is still ethical and just to rely on them in 
directing healthcare. 
 
Conclusion: 
I have argued that because of serious problems with conceptual analysis, the 
disease debate should instead be seen as philosophical explication.  I have then described 
how, within such a project, the Biostatistical Theory can answer important criticisms 
directed towards its criteria or the general philosophical project of defining disease.  
Using this perspective, we can see how a theory from moral philosophy (i.e Daniels’s 
account of healthcare justice) can explain and justify a project in philosophy of science 
and medicine (i.e., the disease debate).  In return, framing the disease debate as 
philosophical explication helps explain the need to draw lines between disease and health 
and the relevance of such lines to justice.    
As mentioned above, one might think that acknowledging that accounts of disease 
depend on normative claims would weaken these theories, since reasonable people can 
disagree about normative issues.   But a theory such as BST may be significantly 
strengthened by acknowledging and explicitly identifying the normative reasons for 
adopting it.  In addition, supporters of a proposed philosophical explication who differ on 
normative questions may find varying, even incompatible, reasons for their support.  A 
libertarian who accepts the BST might well reject support based on Daniels’s account of 
healthcare justice but could embrace other roles the concept could play in medicine or 
ethics.  In this way, a sort of “overlapping consensus” (Rawls 2001) may be formed, of 
individuals who all support some account but do so for divergent reasons. 
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